This article was originally published in The Tan Sheet
Several Blue Cross/Blue Shield Web sites now carrying a two-part report on ephedrine alkaloid-containing dietary supplements. The series, developed by Consumer Health Interactive, discusses side effects and adverse events allegedly related to the supplements, as well as FDA regulatory authority. Scientific issues on ephedrine alkaloid-containing supplements are the focus of a Public Health Service meeting Aug. 8-9 in Washington, D.C. (1"The Tan Sheet" July 10, p. 14)
You may also be interested in...
A government public health expert panel will hear comments on whether ephedrine alkaloid-containing dietary supplements labeled for weight loss and exercise pose risks to consumers at an Aug. 8-9 meeting in Washington, D.C. The meeting is being sponsored by the Office of Women's Health.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning